Small-molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual-inhibiting properties for bladder cancer treatment.
Li G, Song Z, Ru Y, Zhang J, Luo L, Yang W, Wu H, Jin H, Bao X, Wei D, Yan Z, Qu H, Zhu Z, Xue X, Zhou G.
Li G, et al. Among authors: zhou g.
Exploration (Beijing). 2023 Jul 12;3(5):20220141. doi: 10.1002/EXP.20220141. eCollection 2023 Oct.
Exploration (Beijing). 2023.
PMID: 37933289
Free PMC article.